Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.

This study has an unknown status in the United States, in the United Kingdom, in Italy, .... It is testing sulfonylurea for Neurodevelopmental Disorders; Intellectual Disability; Development Delay; ADHD; Autism Spectrum Disorder; Epilepsy.
Current recruitment is not confirmed. Check the official registry or contact the research team before making plans to participate.
Then choose your country and confirm availability with each study site.
This summary needs review. Please check the official study record and contact the research team for details.
Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab)Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
View official study record (opens in a new tab)The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring medication or study treatment for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
This appears to be a medication / drug study involving Sulfonylurea. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.
This study may concern people with adhd; age range: From 2 Years to 50 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
This study is sponsored by Royal Devon and Exeter NHS Foundation Trust, which appears to be a non-profit organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Current recruitment is not confirmed. Check the official registry or contact the research team before making plans to participate.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me